CCL2 and chronic kidney disease: These molecules and others, such as TNF-α, IL-6, and monocyte chemoattractant protein 1 (MCP-1), can promote an inflammatory microenvironment and might be important drivers of inflammation-related injury and enhance progression of CKD [83,85].